TP53 and pancreatic adenocarcinoma: A somatic mutation analysis further showed somatic cell distribution of the TCGA-PAAD cohort, and that KRAS and TP53 frequency changes were the top two mutations in PAAD patients (Supplemental Fig. 1d, p < 0.05).